Yuka Fukuo

Nerima, 1778521, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

A case of complete remission with durvalumab-cabozantinib sequential therapy for advanced hepatocellular carcinoma.

A case of complete remission with durvalumab-cabozantinib sequential therapy for advanced hepatocellular carcinoma.

Journal: Clinical journal of gastroenterology
Published: December 13, 2025

EUS Shear Wave Measurement for Early Chronic Pancreatitis: A Retrospective Diagnostic Accuracy Study Using the 2019 JPS Criteria.

EUS Shear Wave Measurement for Early Chronic Pancreatitis: A Retrospective Diagnostic Accuracy Study Using the 2019 JPS Criteria.

Journal: Journal of clinical medicine
Published: August 05, 2025

Gadoxetic acid-enhanced magnetic resonance imaging predicts early nab-paclitaxel-induced peripheral neuropathy during pancreatic cancer treatment: A pilot study.

Gadoxetic acid-enhanced magnetic resonance imaging predicts early nab-paclitaxel-induced peripheral neuropathy during pancreatic cancer treatment: A pilot study.

Journal: Journal of pharmacological sciences
Published: January 08, 2025

A case of situs inversus totalis with hemosuccus pancreaticus due to intrapancreatic pseudocyst perforation of the common hepatic artery treated with a vascular stent graft.

A case of situs inversus totalis with hemosuccus pancreaticus due to intrapancreatic pseudocyst perforation of the common hepatic artery treated with a vascular stent graft.

Journal: Clinical journal of gastroenterology
Published: July 24, 2024

Real world data of cabozantinib in patients with hepatocellular carcinoma: Focusing on dose setting and modification.

Real world data of cabozantinib in patients with hepatocellular carcinoma: Focusing on dose setting and modification.

Journal: Cancer medicine
Published: July 18, 2024

Remission Factors for Ustekinumab Treatment of Ulcerative Colitis: A Multicenter Retrospective Study of Real-World Data in Japan.

Remission Factors for Ustekinumab Treatment of Ulcerative Colitis: A Multicenter Retrospective Study of Real-World Data in Japan.

Journal: Biomedicines
Published: March 19, 2024

Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.

Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.

Journal: Alimentary pharmacology & therapeutics
Published: November 29, 2023

The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension.

The Impact of Partial Splenic Embolization on Portal Hypertensive Gastropathy in Cirrhotic Patients with Portal Hypertension.

Journal: Journal of clinical medicine
Published: March 08, 2023

Impact of Cabozantinib Exposure on Proteinuria and Muscle Toxicity in Patients with Unresectable Hepatocellular Carcinoma.

Impact of Cabozantinib Exposure on Proteinuria and Muscle Toxicity in Patients with Unresectable Hepatocellular Carcinoma.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 16, 2022

Early Clinical Remission Is a Predictor of Long-Term Remission with the Use of Vedolizumab for Ulcerative Colitis.

Early Clinical Remission Is a Predictor of Long-Term Remission with the Use of Vedolizumab for Ulcerative Colitis.

Journal: Biomedicines
Published: September 06, 2022

Endobronchial Watanabe Spigot Placement for Hepatic Abscess and Bronchobiliary Fistula Following Radiofrequency Ablation for Hepatocellular Carcinoma.

Endobronchial Watanabe Spigot Placement for Hepatic Abscess and Bronchobiliary Fistula Following Radiofrequency Ablation for Hepatocellular Carcinoma.

Journal: Internal medicine (Tokyo, Japan)
Published: August 09, 2022

Plasmablastic Lymphoma of the Small Intestine in an HIV- and EBV-negative Patient.

Plasmablastic Lymphoma of the Small Intestine in an HIV- and EBV-negative Patient.

Journal: Internal medicine (Tokyo, Japan)
Published: March 29, 2021
Showing 1-12 of 17

Last Updated: 09/26/2026